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Abstract: 
Background: PR interval prolongation is associated with poor outcome after cardiac 
resynchronization therapy (CRT) among patients with left bundle branch block (LBBB) but the 
mechanisms are unknown.  We investigated clinical outcomes, electrocardiogram (ECG) and 
echocardiogram changes after CRT by PR interval.  
Methods: This is a retrospective study of CRT recipients with a baseline ejection fraction ≤35% and 
ECG showing sinus rhythm and LBBB. Patients were stratified by baseline PR interval quartile and 
the primary combined endpoint was time to heart transplantation, left ventricular assist device 
(LVAD) implantation or death.  ECG, echocardiogram and clinical variables were compared to 
identify mechanisms for observed differences in outcomes. 
Results: Of 291 eligible patients, the mean age was 65 years, 60% were male, and 19% had prior atrial 
fibrillation.  Patients with PR prolongation (quartile 4, PR >200ms) more frequently had a history of 
atrial fibrillation, coronary artery bypass graft surgery, prior implantable cardioverter defibrillator 
implantation, and use of amiodarone than patients in PR quartiles 1-3.  A PR >200ms was associated 
with an adjusted hazard ratio of 1.7 (95% CI 1.1-2.5) for the primary endpoint.  Patients with PR 
>200ms had less reduction in QRS duration and QRS area after CRT while having more increase in 
QT and QTc intervals than patients with PR ≤200 ms. No major differences were observed in 
echocardiography by baseline PR interval quartiles. 
Conclusions: PR prolongation predicts shorter survival free of heart transplantation or LVAD 
implantation in patients with LBBB.  This may be due to inadequate ventricular resynchronization. 
 
Keywords 
Electrocardiology; PR interval; Cardiac Resynchronization Therapy; Electrophysiology; 
Echocardiography; Mortality/Survival 
 
Introduction:  
Prolongation of the electrocardiogram (ECG) PR interval > 200 ms is associated with increased 
adjusted risks of atrial fibrillation and all-cause mortality(1-4). Prior studies on the association 
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3 
between baseline PR interval and outcomes after cardiac resynchronization therapy (CRT) are 
conflicting, patients with left bundle branch block (LBBB) and prolonged baseline PR interval have 
increased likelihood of heart failure related hospitalization or death after CRT compared to patients 
with LBBB normal baseline PR interval while patients with non-LBBB conduction abnormalities and 
PR prolongation may have lower likelihood of adverse events after CRT compared to patients with 
non-LBBB conduction abnormalities and normal PR interval (5-7).  Whether the poorer outcomes 
after CRT among patients with LBBB and PR prolongation are related to a higher burden of medical 
comorbidity or if different implantation, programming or follow-up techniques may be needed to 
optimize outcomes remains unclear. Little information is available comparing the ECG and 
echocardiographic response to CRT among patients with normal and prolonged baseline PR interval 
and LBBB and prior studies are limited by lack of data regarding device programming and 
biventricular pacing percentage.(4) To better understand possible mechanisms for poor CRT 
outcomes, we performed a retrospective single center analysis to compare the clinical, ECG, and 
echocardiographic response to CRT among patients with LBBB and prolonged PR interval and those 
with normal PR interval. 
 
Methods:  
Study population: 
This is a retrospective analysis of patients who received a de novo implantation of a CRT-
defibrillator at Duke University Medical Center between April 2006 and September 2015.  Patients 
were identified using an institutional dataset created for submission to the National Cardiovascular 
Data Registry.  For this study patients were required to have an echocardiogram performed within 365 
days of CRT-D implantation demonstrating a left ventricular ejection fraction (LVEF) of ≤ 35% and a 
digital ECG at baseline (≤ 180 days prior to CRT implantation) demonstrating a QRS ≥ 120ms with 
left bundle branch block morphology and follow up ECG ≤ 90 days after the index procedure 
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4 
demonstrating CRT pacing.  Patients were excluded if they died prior to discharge, if they were not in 
normal sinus rhythm (NSR) on the baseline ECG or if they had evidence of 2
nd
 or 3
rd
 degree 
atrioventricular (AV) block. If multiple ECGs were available in the allowable pre- and/or post-CRT 
time frame the ECG closest to the procedure date was utilized. The study was approved by the Duke 
Institutional Review Board. 
ECG Analyses: 
Clinically obtained ECGs were reanalyzed using the GE MUSE Cardiology Information 
System version 8.0.2.0132 with analysis software version 241 (GE Healthcare, Chicago Il, USA) and 
exported in .XML format.  QRS morphology was designated by two readers (DF and KE) blinded to 
outcome. Left bundle branch block (LBBB) morphology was defined according to previously 
accepted criteria including QRS duration  120 ms, QS or rS in lead V1, broad R waves in leads I, 
aVL, V5, or V6, and absent Q waves in leads V5 and V6 (8). LBBB was further divided into strict and 
non-strict LBBB using the Strauss criteria(9). P wave, QRS, and QT onset and offset and thereby P 
wave duration, PR interval, QRS duration, and QT interval as detected by the software were over read 
and manually corrected if needed. The QT interval was corrected (QTc) using the Freiderica formula.  
P wave dispersion was calculated as the maximum P wave duration minus the minimum P wave 
duration on a 10 second ECG. Vectorcardiograms were derived from the XML files using customized 
MATLAB software (MathWorks, Inc., Natick, MA, USA) using the Kors matrix.(10)  
Device Follow-Up Data: 
Patients were longitudinally followed using remote patient monitoring or in-clinic device 
interrogation and reports were retrospectively reviewed in the electronic medical record.  To be 
included in analyses of device follow-up, data must have been acquired at least 30 days after 
implantation.  If multiple follow-up reports were available in the electronic medical record, device 
data obtained as close as possible to 180 days after implantation was used. 
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End Points: 
The primary clinical study endpoint was incident left ventricular assist device (LVAD), 
cardiac transplant, or all-cause death.  Endpoint occurrence was determined via a May 24, 2017 query 
of the Duke Enterprise Data Unified Content Explorer, which incorporates data from billing claims, 
hospital records, and the Social Security Death Index.(11) The echocardiographic imaging study 
endpoints were % change in LV end systolic volume (LVESV),  % change in LV end diastolic 
volume (LVEDV) and absolute % change in LVEF.  The ECG endpoints were % change in PR 
interval, % change in QRS duration, % change in QRS area, % change in QT interval, and % change 
in corrected QT interval. Because prior studies have shown that the relationship between baseline PR 
interval and CRT outcomes is non-linear, the primary clinical analysis compared outcomes by 
baseline PR interval quartile. To further explore the results of the primary clinical endpoint, all further 
analyses compared PR interval quartile 4 (PR interval > 200 ms) to PR interval quartiles 1-3 (PR ≤ 
200ms). 
Statistical Analyses: 
Baseline characteristics of the study population were compared using frequencies with 
percentages for categorical variables and means with standard deviations or medians with interquartile 
range for continuous variables. Differences between groups were compared using the chi-square tests 
for categorical variables and Wilcoxon rank-sum tests or student’s T-tests for continuous variables. 
Because prior studies (4)have shown that the relationship between baseline PR interval and CRT 
outcomes is non-linear, the primary clinical analysis compared outcomes by baseline PR interval 
quartile. The unadjusted association between baseline PR interval quartile and time to LVAD, 
transplant or death was depicted using a Kaplan Meier plot and differences were assessed using the 
Log Rank test.  To further explore the results of the primary clinical endpoint, all further analyses 
compared PR interval quartile 4 to PR interval quartiles 1-3.  The adjusted long term association 
between baseline PR interval quartile (quartile 4 vs. quartiles 1-3) and time to LVAD, transplant, or 
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death was assessed using Cox proportional hazards models.  All variables that differed between 
patients in quartile 4 and quartiles 1-3 were included in the adjusted analysis, including QRS duration, 
QRS area, prior CABG, prior ICD, prior cardiac arrest, ICD indication, prior atrial fibrillation, and 
prior or current amiodarone use.  Statistical analyses were performed in JMP Pro Version 13.1 (SAS, 
Cary, NC).  A P < 0.05 was considered statistically significant for all tests. 
Results: 
A total of 1001 patients underwent CRT-D implant during the study period; 162 patients were 
excluded for a missing or low quality baseline ECG, 335 patients were excluded for non-LBBB QRS 
morphology, 59 patients were excluded for atrial fibrillation or flutter on the baseline ECG, and 14 
patients were excluded for 2
nd
 or 3
rd
 degree AV block on the baseline ECG. A total of 126 patients 
were excluded for lack of baseline echocardiogram and 13 patients were excluded because baseline 
echo images were low quality and uninterpretable. One patient was excluded because of failure to 
place an LV lead leaving a total of 291 patients available for analysis. 
 
Baseline Patient Characteristics by PR Interval Quartile: 
Patient characteristics at the time of CRT implantation are shown in Table 1.  The range of 
PR interval in each quartile were: quartile 1= 86 - 164ms, quartile 2= 165 - 180ms, quartile 3= 181 - 
200ms and quartile 4= 201 - 380ms.  Patients in PR interval quartile 4 more frequently had a history 
of coronary artery bypass surgery, a secondary prevention indication for ICD implantation, prior ICD 
implantation, cardiac arrest, atrial fibrillation or flutter, and were more likely to be treated with 
amiodarone.  Patients in PR interval quartile 4 also had more P wave dispersion, slower ventricular 
rate, longer QRS duration and QT interval, and smaller QRS area than patients in PR interval quartiles 
1-3 (Table 2).  They also had more prolonged isovolumic contraction time (ICT) on tissue Doppler 
echocardiography, but similar baseline LVEF, LV size, and diastolic filling time. 
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Clinical End Points:   
Over a median follow-up of 3.1 years (1.7 - 5.9 years), 120 (41%) patients reached the 
primary combined endpoint.  The study end point was death in 99 (34%) patients, LVAD implantation 
in 12 (4%) patients, and heart transplantation in 9 (3%) patients.  The combined clinical endpoint 
occurred in 22/72 (31%) patients in PR interval quartile 1, 29/73 (40%) patients in quartile 2, 26/73 
(36%) patients in quartile 3, and 43/73 (59%) patients in quartile 4 (Figure 1). Baseline PR interval in 
quartile 4 was associated with an unadjusted HR of 2.7 (95% CI 1.6-4.6, P < 0.0001) compared to PR 
quartile 1, HR 1.9 (95% CI 1.2-3.1, P = 0.007) compared to PR quartile 2, and HR 2.7 (95% CI 1.7-
4.5, P < 0.0001) compared to PR quartile 3 for reaching the combined clinical endpoint. Because PR 
interval quartile 4 differed from PR interval quartiles 1-3 but PR quartiles 1-3 had no significant 
differences with each other in survival, all further analyses were performed comparing PR interval 
quartile 4 to the combined PR interval quartiles 1-3.  After combining PR interval quartiles 1-3, 
baseline PR interval in quartile 4 was associated with an unadjusted HR of 2.4 for reaching the 
combined clinical endpoint  (95% CI 1.6-3.5, P < 0.0001). Baseline PR interval in quartile 4 remained 
predictive of time to combined clinical endpoint after adjustment for differences in baseline covariates 
with a HR of 1.7 (95% CI 1.1-2.5, P = 0.02).  Median survival free of heart transplant or LVAD after 
CRT implantation was 3.3 (IQR 1.5-6.9) years for patients in PR quartile 4 versus 9.6 (IQR 3.1->10) 
years for patients in PR interval quartiles 1-3. 
 
Device Programming and Follow-up Device Data by Baseline PR Interval Quartile: 
Follow-up device data were available in 253 (87%) patients.  The median time from implant 
to follow-up device interrogation was 202 days (134 - 296 days). There was no difference in the time 
from implant to device follow-up between PR interval quartile 4 and PR interval quartiles 1-3 (Table 
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3).  At follow-up, there were no significant differences in the frequency of DDD, DDDR, VVI, or 
VVIR programming modes, or the frequency of use of adaptive LV only pacing or programmed AV 
intervals across the baseline PR interval quartiles. Patients in PR interval quartile 4 had a higher mean 
programmed lower rate limit, (57 ± 8 beats per minute vs. 55 ± 7 beats per minute, P = 0.03). Despite 
differences in the frequency of history atrial fibrillation or flutter at CRT implant, there were no 
differences in the mean atrial fibrillation burden or mean percentage of biventricular pacing between 
PR interval quartiles 1-3 and PR interval quartile 4 on follow-up device interrogation.  Patients in PR 
interval quartile 4 received more ICD shocks per patient than patients in the combined PR interval 
quartiles 1-3, 17 shocks occurred in 57 patients with device follow up data in PR interval quartile 4 
(0.3 shocks per patient) vs. 17 shocks in 187 patients (0.09 shocks per patient) in PR interval quartiles 
1-3.  These differences were not significant after adjusting for time of follow-up, patients in PR 
interval quartile 4 received 0.5 ± 3 shocks per life year of follow-up while patients in PR interval 
quartiles 1-3 received 0.2 ± 1.4 shocks per life year of follow-up  (P = 0.27 for difference). 
 
ECG Endpoints: 
A total of 211 (72%) patients had follow-up CRT paced ECGs available for analysis. There 
were no differences in the CRT paced PR interval or heart rate between patients in baseline PR 
interval quartile 4 and quartiles 1-3.  Patients in baseline PR interval quartile 4 had more prolonged 
CRT paced QRS duration (146 ± 21 ms vs. 163 ± 22 ms, P < 0.01), QT interval (463 ± 47 ms vs. 494 
± 43 ms, P < 0.01), and QTc (512 ± 39 ms vs. 541 ms ± 42 ms, P < 0.01) interval than patients in PR 
interval quartiles 1-3. Patients in PR interval quartile 4 also had significantly larger CRT paced QRS 
area than patients in PR interval quartile 1-3, 76 ± 35 µVs vs. 65 ± 31 µVs (P = 0.04). Patients in 
baseline PR interval quartile 4 had significantly less reduction in QRS duration and QRS area while 
having significantly more increase in QT and QTc intervals than patients in PR interval quartiles 1-3 
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(Figure 2). After CRT, patients in baseline PR quartile 4 (PR > 200 ms) had less reduction in QRS 
duration and QRS area than patients in PR quartiles 1-3, (0 ± 22 ms vs. -9 ± 23 ms, P = 0.01) and (-21 
± 37 µVs vs. -43 ± 44 µVs, P < 0.01), respectively.  Patients in baseline PR quartile 4 also had more 
QT and QTc prolongation after CRT pacing than patients in PR quartiles 1-3 (29 ± 45 ms vs. 13 ± 40 
ms, P<0.01) and (41 ± 44 ms vs. 15 ± 38 ms, P < 0.01) respectively. 
 
Echocardiographic Endpoints: 
A total of 123 (42%) patients had follow-up echocardiograms available for analysis. There 
were no significant differences between baseline PR interval quartiles 1-3 and quartile 4 for changes 
in LVEF, LVESV, LVEDV, global longitudinal strain, or longitudinal strain pattern after CRT 
pacing. (Table 3) 
Discussion 
In this single center study we used detailed ECG and echocardiographic data to explore 
mechanisms that may explain the poor outcomes observed after CRT implantation among patients 
with prolonged baseline PR interval. Specifically, we sought to compare the burden of medical 
comorbidity, presence or absence of ECG and echocardiographically identifiable dyssynchrony, and 
the degree of correction of that dyssynchrony during CRT pacing across PR interval quartiles.  First, 
we confirmed that patients with baseline PR interval prolongation (> 200 ms, PR interval quartile 4) 
experienced increased risk of death, LVAD implantation, or heart transplantation after CRT 
implantation.  We also confirmed findings from other studies that patients undergoing CRT 
implantation with baseline PR interval > 200 ms (quartile 4) more frequently had a prior history of 
atrial fibrillation, ischemic heart disease, coronary artery bypass grafting surgery and prior ICD 
implantation. After adjustment for these differences, patients with prolonged baseline PR interval 
continued to demonstrate shorter survival free of LVAD or heart transplant, confirming prior findings 
 
 
 
This article is protected by copyright. All rights reserved. 
 
10 
that differences in baseline characteristics do not fully explain the observed differences in outcomes 
after CRT implantation.(5) 
Prior work suggests that differences in CRT response observed between patients with various 
conduction abnormalities can largely be explained by differences in underlying intrinsic electrical 
substrate(12). We used echocardiogram and ECG data to evaluate whether differences in electrical 
and mechanical intrinsic substrate may explain the differences in survival seen between patients with 
prolonged PR interval and those with normal PR interval and found that overall patients with baseline 
PR interval prolongation had similar intrinsic substrates for CRT based on several commonly used 
metrics. In fact, patients with baseline PR interval in quartile 4 (> 200 ms) had more prolonged 
baseline QRS duration than patients with normal PR interval with equal likelihood of a strict LBBB 
QRS configuration. Echocardiography showed that patients with prolonged PR interval had more 
prolonged ICT than patients with normal baseline PR interval, suggesting that they may have more to 
gain from improvement of LV filling and dP/dT through CRT than patients with normal PR 
interval(13). Of interest, although the QRS duration was more prolonged in PR quartile 4 than other 
quartiles, the QRS area was significantly smaller. QRS area has recently proven to be a powerful 
predictor of CRT outcomes and may be a better tool than QRS duration for measurement of intrinsic 
global ventricular dyssynchrony(14,15). Thus, although several commonly used tools suggest similar 
substrate among patients with a prolonged versus normal PR interval, QRS area assessment suggests 
that patients with a prolonged PR interval may have less global ventricular dyssynchrony at baseline 
and thus may have less to gain with resynchronization therapy. 
Next, we investigated whether CRT delivery differed among patients with prolonged PR 
interval and patients with normal PR interval.  We found that patients with prolonged PR had similar 
biventricular pacing %, similar AF burden after CRT implantation, and similar programmed pacing 
parameters.  Despite the similarities in device programming, patients with prolonged baseline PR 
interval had less reduction in QRS duration and QRS area than patients with normal PR interval, 
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suggesting inadequate electrical resynchronization of underlying electrical dyssynchrony may be 
common in patients with prolonged PR interval.  Prior studies suggest that patients with LBBB and 
normal PR interval have intact right bundle branch and septal fascicular conduction that contribute to 
ventricular depolarization during CRT pacing while little or no contribution is present in patients with 
PR prolongation.(16) This is the physiological basis for adaptive LV only pacing.  The additional 
contribution of the intact right bundle and septal fascicles to biventricular paced ventricular 
depolarization among patients with normal PR interval may provide a more synchronous overall LV 
activation than pure biventricular pacing using an epicardial LV lead and an RV endocardial lead 
among patients with PR prolongation, explaining the more significant reductions in QRS duration and 
QRS area among patients with normal baseline PR interval.  Future studies exploring alternative CRT 
pacing strategies such as multipoint pacing, LV endocardial pacing, His bundle pacing, or a 
combination of His bundle and LV epicardial pacing(17) may provide opportunities to improve 
outcomes for patients with intrinsic PR prolongation.   
Finally, patients with baseline PR prolongation more often experienced VT/VF events 
requiring ICD shock during follow-up, although in the modest sample size these differences did not 
reach significance. At baseline they were more likely to have a secondary ICD indication for sudden 
cardiac death prevention, a history of prior ICD implantation, prior cardiac arrest, use of amiodarone, 
and QT prolongation, all potentially increasing the likelihood of arrhythmic events.  We found that 
baseline PR prolongation was also associated with more severe prolongation of the QT and QTc 
intervals after CRT pacing.  It is possible that this group experiences a higher likelihood of developing 
intramyocardial repolarization heterogeneities with CRT pacing, which could be proarrhythmic.  
Further work examining the role of repolarization on predicting outcomes after CRT pacing is needed.  
Limitations:   
The major limitations of this study are the retrospective design and the lack of a control group 
who did not receive CRT. As a result, the treatment effect of CRT implantation in patients with PR 
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interval prolongation cannot be established. The single center nature of the study limits 
generalizability of the findings. Cardiac resonance imaging data were unavailable, as a result we were 
unable to compare differences in ventricular scar burden between patients with normal versus 
prolonged PR interval.  Left ventricular lead position is an important predictor of CRT outcomes and 
was not available in the dataset; if different across PR interval quartiles this may account for the 
observed differences in outcomes.  The severity of heart failure symptoms was available at baseline 
but was not available at follow-up, preventing us from assessing this important CRT endpoint.  
Finally, ECG and echocardiogram data were missing in some patients, limiting our ability to detect 
differences in ECG and especially echocardiographic response to CRT across PR interval quartiles. 
Conclusion:  
CRT recipients with prolonged baseline PR interval have shorter survival free of heart transplant or 
LVAD therapy after CRT than patients with normal PR interval. While comorbidities may play a role 
in this association, it also appears that patients with prolonged baseline PR interval experience less 
resynchronizing effect of CRT than patients with normal PR interval despite generally similar 
intrinsic substrates for resynchronization at baseline. 
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 Figure 1 (central figure): Kaplan-Meier survival plots by baseline PR interval quartile.  Log-
Rank test P < 0.0001.  Red line = baseline PR interval quartile 1, Green line = baseline PR 
interval quartile 2, Blue line = baseline PR interval quartile 3, Orange Line = baseline PR interval 
quartile 4. 
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Figure 2:  Change in QRS duration (Panel A), QRS area by Kors transformation method (Panel B), 
QT interval (Panel C) and corrected QT interval (Panel D) stratified by baseline PR interval 
quartile 1-3 versus 4.   
 
Table 1:  Baseline patient clinical characteristics. 
Variable Total Quartile 1-3, 
PR=86-200ms 
Quartile 4, 
PR=201-380ms 
P-value 
N 291 218 73  
Age (years), mean (SD) 65 (11.5) 64 (12) 67 (11) 0.13 
Sex (female) 117 (40) 91 (42) 26 (36) 0.47 
Race    0.34 
Black 68 (23) 54 (25) 14 (19)  
White 132 (45) 100 (46) 32 (44)  
Other 9 (2) 5 (2) 4 (5)  
Missing 82 (28) 59 (27) 23 (32)  
Ischemic 133 (46) 93 (43) 40 (55) 0.08 
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Cardiomyopathy 
CABG 73 (25) 46 (21) 27 (37) <0.01 
NYHA Class    0.92 
I 10 (3) 7 (3) 3 (4)  
II 48 (16) 36 (17) 12 (16)  
III 224 (77) 169 (78) 55 (75)  
IV 9 (3) 6 (3) 3 (4)  
Duration of Heart Failure 
< 3 months 
3-9 months 
> 9 months 
 
10 (3) 
43 (15) 
233 (81) 
 
9 (4) 
37 (17) 
168 (79) 
 
1 (1) 
6 (8) 
65 (90) 
0.06 
ICD Indication 
Primary Prevention 
Secondary Prevention 
 
262 (90) 
29 (10) 
 
202 (93) 
16 (7) 
 
60 (82) 
13 (18) 
0.01 
Prior ICD 45 (15) 23 (11) 22 (30) <0.01 
Cardiac Arrest 17 (6) 8 (4) 9 (12) 0.01 
Diabetes 88 (30) 60 (28) 28 (38) 0.09 
Hypertension 200 (69) 145 (67) 55 (75) 0.15 
Atrial Fibrillation or 
Flutter 
55 (19) 29 (13) 26 (36) <0.01 
Chronic Lung Disease 55 (19) 41 (19) 14 (19) 0.94 
Cerebrovascular Disease 29 (10) 19 (9) 10 (14) 0.23 
Creatinine (mg/dL) 1.5 (1.5) 1.4 (1.4) 1.8 (1.7) 0.06 
Amiodarone 41 (14) 19 (8.8) 22 (30) <0.01 
Beta Blocker 263 (91) 200 (93) 63 (86) 0.12 
ACE or ARB 236 (82) 182 (84) 54 (74) 0.06 
ACE = angiotensin converting enzyme, ARB = angiotensin receptor blocker, CABG = coronary 
artery bypass graft surgery, ICD = implantable cardioverter-defibrillator, NYHA = New York Heart 
Association. 
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Table 2: Baseline ECG and echocardiographic patient characteristics. 
Variable Total Quartile 1-3, 
PR=86-200ms 
Quartile 4, 
PR=201-380ms 
P-value 
N 291 218 73  
QRS Morphology     
Strict LBBB (%) 235 (81) 175 (80) 60 (82) 0.71 
ECG Intervals     
         PR Interval (ms) 185 (36) 171 (20) 231 (36) <0.01 
P Duration (ms) 114 (18) 112 (15) 118 (23) 0.05 
P Dispersion (ms) 76 (20) 74 (20) 82 (22) 0.02 
Ventricular Rate 
(BPM) 
74 (14) 75 (14) 71 (13) 0.02 
QRS Duration (ms) 157 (21) 155 (20) 162 (23) 0.04 
QT Interval (ms) 454 (40) 451 (38) 465 (45) 0.02 
QT Corrected (ms) 498 (38) 498 (37) 499 (39) 0.82 
QRS Area (µVs) 104 (42) 108 (43) 93 (36) <0.01 
LVEF (%) 24 (9) 24 (9) 23 (9) 0.59 
LVEDV (mL) 220 (84) 218 (86) 230 (80) 0.29 
LVESV (mL) 172 (79) 169 (80) 180 (76) 0.32 
Isovolumic Contraction 
Time (ms) 
130 (34) 127 (33) 139 (37) 0.04 
Ejection Time (ms) 264 (38) 263 (39) 268 (37) 0.37 
Isovolumic Relaxation 
Time (ms) 
141 (37) 143 (35) 136 [115. 165] 0.26 
Diastolic Filling Time 
(ms) 
320 (136) 312 (134) 308 (142) 0.87 
Diastolic Filling Time (% 
RR) 
35 (9) 36 (9) 35 (10) 0.64 
Myocardial Performance 
Index 
1.05 (0.27) 1.05 (0.26) 1.04 (0.29) 0.86 
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Global Longitudinal Strain 
(%) 
-8.1 (3.6) -8.3 (3.8) -7.6 (3.3) 0.18 
Longitudinal Strain Pattern 
Classical 
Other 
 
186 (64) 
105 (36) 
 
139 (64) 
79 (36) 
 
47 (64) 
26 (36) 
0.92 
LVEF = left ventricular ejection fraction, LVEDV = left ventricular end diastolic volume, LVESV = 
left ventricular end systolic volume. 
 
Table 3: Follow up device programming, ECG and echocardiographic data. 
Variable Total Quartile 1-3, 
PR=86-200ms 
Quartile 4, 
PR=201-380ms 
P-value 
Device Programming and Pacing 
Characteristics at Follow-up, N 
251 192 59  
Time from implant to follow-up 
(days), median, (IQR) 
202 (134-
296) 
202 (139-305) 204 (110-288) 0.81 
Pacing Mode     0.10 
DDD, n (%) 178 (71) 141 (73) 37 (63)  
DDDR, n (%) 70 (28) 48 (25) 22 (37)  
VVI, n (%) 3 (1) 3 (2) 0 (0)  
Adaptive CRT, n (%) 43 (17) 29 (15) 14 (24) 0.33 
Lower Rate Limit (BPM) 55 (8) 55 (7) 57 (8) 0.03 
Paced AV Delay (ms) 146 (32) 143 (31) 152 (35) 0.09 
Sensed AV Delay (ms) 111 (32) 110 (30) 115 (38) 0.33 
LV to RV Delay (ms)* -11 (17) -14 (18) -4 (13) <0.01 
CRT (BIV or LV only) Pacing (%) 95 (13) 96 (13) 94 (14) 0.55 
AF Burden (%) 2.4 (13) 1.9 (13) 3.7 (14) 0.40 
VT/VF Therapies (n/person years 
follow-up) 
0.3 (1.9) 0.2 (1.4) 0.5 (3) 0.27 
Follow-Up ECG Characteristics, N 211 153 58  
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Atrial Rhythm    0.05 
Sinus 173 (82) 132 (85) 41 (71)  
Atrial Paced 37 (17) 21 (14) 16 (28)  
Atrial Fibrillation 2 (1) 1 (1) 1 (1)  
PR Interval (ms) 140 (32) 138 (33) 143 (33) 0.42 
Ventricular Rate (BPM) 75 (14) 75 (15) 74 (14) 0.44 
QRS Duration (ms) 151 (23) 146 (21) 163 (22) <0.01 
QRS Area (µVs) 68 (32) 65 (31) 76 (35) 0.04 
QT Interval (ms) 472 (48) 463 (47) 494 (43) <0.01 
QT Corrected (ms) 520 (42) 512 (39) 541 (42) <0.01 
Echo Characteristics for Patients 
with Baseline and Follow-up 
Studies, N 
123 97 26  
Change in LVEF (%) 9 (10) 8 (11) 10 (8) 0.36 
Change in LVEDV (mL) -29 (54) -33 (54) -13 (53) 0.09 
Change in LVESV (mL) -37 (53) -38 (54) -30 (51) 0.48 
Change in Global Longitudinal Strain 
(%) 
-2.7 (4.2) -2.7 (4.3) -2.7 (4.2) 0.98 
Follow up Longitudinal Strain Pattern 
Classical 
Other 
 
19 (15) 
104 (85) 
 
14 (14) 
83 (86) 
 
5 (19) 
21 (81) 
0.55 
AF = atrial fibrillation, AV = atrio-ventricular, BIV = biventricular, CRT = cardiac resynchronization 
therapy, IQR = interquartile range, LV = left ventricular, LVEF = left ventricular ejection fraction, 
LVEDV = left ventricular end diastolic volume, LVESV = left ventricular end systolic volume. 
*Among patients programmed to standard Biventricular (non-Adaptive LV only) CRT pacing. 
 
 
 
